The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.
Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C.
Steckelings UM, et al. Among authors: unger t.
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
Pharmacol Rev. 2022.
PMID: 36180112
Free PMC article.
Review.